Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Research

Intravenously administered vitamin C as cancer therapy: three cases

Sebastian J. Padayatty, Hugh D. Riordan, Stephen M. Hewitt, Arie Katz, L. John Hoffer and Mark Levine
CMAJ March 28, 2006 174 (7) 937-942; DOI: https://doi.org/10.1503/cmaj.050346
Sebastian J. Padayatty
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hugh D. Riordan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen M. Hewitt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arie Katz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. John Hoffer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Levine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint

    Fig. 1: Chest radiography, November 1996, about 1 month after intravenous vitamin C therapy was started. Cannonball lesions are evident in both lung fields, as indicated by the arrows and lines.

  • Figure2
    • Download figure
    • Open in new tab
    • Download powerpoint

    Fig. 2: Chest radiography, June 1997, showing regression of the lesions; the arrow indicates one residual abnormality.

Tables

  • Figures
  • Table 1.

    Table1
  • Table 2.

    Table2
  • Table 3.

    Table3
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 174 (7)
CMAJ
Vol. 174, Issue 7
28 Mar 2006
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Intravenously administered vitamin C as cancer therapy: three cases
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Intravenously administered vitamin C as cancer therapy: three cases
Sebastian J. Padayatty, Hugh D. Riordan, Stephen M. Hewitt, Arie Katz, L. John Hoffer, Mark Levine
CMAJ Mar 2006, 174 (7) 937-942; DOI: 10.1503/cmaj.050346

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Intravenously administered vitamin C as cancer therapy: three cases
Sebastian J. Padayatty, Hugh D. Riordan, Stephen M. Hewitt, Arie Katz, L. John Hoffer, Mark Levine
CMAJ Mar 2006, 174 (7) 937-942; DOI: 10.1503/cmaj.050346
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Patient 1
    • Patient 2
    • Patient 3
    • Discussion
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights of this issue
  • Dans ce numéro
  • High-dose vitamin C therapy: Renewed hope or false promise?
  • PubMed
  • Google Scholar

Cited By...

  • Effect of High-dose Vitamin C Combined With Anti-cancer Treatment on Breast Cancer Cells
  • Influence of Vitamin C on Urine Dipstick Test Results
  • The Impact of High-Dose Vitamin C on Blood Glucose Testing in 18F-FDG PET Imaging
  • Is There a Role for Oral or Intravenous Ascorbate (Vitamin C) in Treating Patients With Cancer? A Systematic Review
  • High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy
  • Clinical Experience of Integrative Cancer Immunotherapy with GcMAF
  • Intravenous Vitamin C Administration Improves Quality of Life in Breast Cancer Patients during Chemo-/Radiotherapy and Aftercare: Results of a Retrospective, Multicentre, Epidemiological Cohort Study in Germany
  • Pharmacological Ascorbic Acid Suppresses Syngeneic Tumor Growth and Metastases in Hormone-refractory Prostate Cancer
  • High-dose Vitamin C (Ascorbic Acid) Therapy in the Treatment of Patients with Advanced Cancer
  • Reply to Borst: Randomized clinical trials of high-dose intravenous vitamin C in cancer patients are warranted
  • Mega-dose vitamin C as therapy for human cancer?
  • Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice
  • Vitamin C and cancer revisited
  • New Developments and Novel Therapeutic Perspectives for Vitamin C
  • Tumor Suppressor 101F6 and Ascorbate Synergistically and Selectively Inhibit Non-Small Cell Lung Cancer Growth by Caspase-Independent Apoptosis and Autophagy
  • Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo
  • High-dose vitamin C therapy: renewed hope or false promise?
  • Google Scholar

More in this TOC Section

  • Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19–related deaths among people with multimorbidity: a cohort study
  • Association between virtual primary care and emergency department use during the first year of the COVID-19 pandemic in Ontario, Canada
  • Survival and health care costs after inpatient elective surgery: comparison of patients with and without chronic obstructive pulmonary disease
Show more Research

Similar Articles

Collections

  • Topics
    • Cancer & oncology
    • Complementary medicine & alternative therapies

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire